(93 days)
Not Found
No
The description focuses on controlled fluid delivery and image integration for display and printing, with no mention of AI or ML for analysis or decision-making.
Yes
The device is intended for the "delivery of medication and/or fluids in a controlled manner" and is "indicated for use in the intermittent delivery of medications and other fluids in intra-articular applications," which are therapeutic actions.
No
The device is intended for the delivery of medication and fluids, not for diagnosing conditions. While it can integrate with ultrasound for imaging purposes, its primary function is therapeutic delivery.
No
The device description explicitly lists multiple hardware components: a fluid delivery module, a daily disposable cassette, a per-patient disposable handpiece and tubing set, and a wired foot pedal.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "delivery of medication and/or fluids in a controlled manner" and specifically for "intermittent delivery of medications and other fluids in intra-articular applications." This describes a therapeutic or procedural device, not a device used to examine specimens derived from the human body to provide information for diagnosis, monitoring, or screening.
- Device Description: The components listed (fluid delivery module, cassette, handpiece, tubing set, foot pedal) are consistent with a system for delivering substances into the body. While it mentions image integration with ultrasound, this is for visualization during the procedure, not for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological specimens (blood, urine, tissue, etc.), reagents, or any process related to in vitro testing.
Therefore, the Navigator Delivery System is a medical device used for delivering substances into the body, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The NavigatorTM Delivery System (Navigator DS) is intended for use in the delivery of medication and/or fluids in a controlled manner. The Navigator DS is indicated for use in the intermittent delivery of medications and other fluids in intra-articular applications.
Product codes (comma separated list FDA assigned to the subject device)
FRN
Device Description
The Navigator Delivery System (Navigator DS) consists of a fluid delivery module, a daily disposable cassette, a per-patient disposable handpiece and tubing set, and wired foot pedal. Image integration with qualified ultrasound units occurs by Ethernet cable connection, if desired, allowing simultaneous display of Navigator treatment information on the ultrasound screen and printing of ultrasound images on the patient treatment record.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
ultrasound
Anatomical Site
intra-articular
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing of the Navigator DS was carried out, including performance testing. All data demonstrated that the safety and performance of the Navigator DS is not affected by the modification.
A Clinical Evaluation was determined not to be required as the device design, intended use and indication for use are preserved.
A Safety Case and Hazard Analysis demonstrated an acceptable risk profile based on design-based risk mitigation and satisfactory performance testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
510(k) Summary
SUBMITTER'S INFORMATION
| Owner: | Carticept Medical, Inc. |
|---|---|
| Address: | 6120 Windward Parkway, Suite 220, Alpharetta, GA 30005 |
| Phone: | 770-754-3800 |
| Fax Numbers: | 770-754-3808 |
| Contact Person: | Tanya Eberle, Director, Regulatory Affairs |
| Date Summary Prepared: | July 24, 2012 |
DEVICE INFORMATION
| Name of Device: | NavigatorTM Delivery System (Navigator DS) |
|---|---|
| Common/Usual Name: | Infusion Pump, External |
| Classification Name: | Infusion Pump, Class II, 21 CFR 880.5725 (Product Code FRN) |
| Predicate Device(s): | NavigatorTM Delivery System (K120830) |
| Device Description: | The Navigator Delivery System (Navigator DS) consists of a fluid |
| delivery module, a daily disposable cassette, a per-patient | |
| disposable handpiece and tubing set, and wired foot pedal. | |
| Image integration with qualified ultrasound units occurs by | |
| Ethernet cable connection, if desired, allowing simultaneous | |
| display of Navigator treatment information on the ultrasound | |
| screen and printing of ultrasound images on the patient | |
| treatment record. | |
| Indication for Use: | The NavigatorTM Delivery System (Navigator DS) is intended for |
| use in the delivery of medication and/or fluids in a controlled | |
| manner. The Navigator DS is indicated for use in the | |
| intermittent delivery of medications and other fluids in intra- | |
| articular applications. | |
| Technological | |
| Characteristics: | All technological and design aspects of the Navigator DS device |
| are preserved. | |
| Comparison to Predicate | |
| Device: | The Navigator DS intended use and performance characteristics |
| are not altered by this modification. |
OC
1
Performance Data:
Testing of the Navigator DS was carried out, including performance testing. All data demonstrated that the safety and performance of the Navigator DS is not affected by the modification.
A Clinical Evaluation was determined not to be required as the device design, intended use and indication for use are preserved.
A Safety Case and Hazard Analysis demonstrated an acceptable risk profile based on design-based risk mitigation and satisfactory performance testing.
Rationale for Substantial Equivalence:
This minor modification falls within the FDA regulations for 510(k) review. The indication for use, intended use, technological characteristics, principles of operation, and performance have not been altered. The modification of resistance thresholds does not raise any new questions of safety or effectiveness and the system has been demonstrated to provide the same level of performance as the predicate device. The Navigator DS with modified resistance thresholds is substantially equivalent to the predicate device (Navigator DS K120830).
Conclusion:
The Navigator DS, as modified by this 510(k), does not raise any new issues regarding safety or effectiveness, and therefore is suitable for commercial sale.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. In the center of the seal is an abstract image of a bird-like figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
OCT 2 6 2012
Carticept Medical, Incorporated Ms. Tanya Eberle Director, Regulatory Affairs 6120 Windward Parkway, Suite 220 Alpharetta, Georgia 30005
Re: K122215
Trade/Device Name: Navigator Delivery System (Navigator DS) Regulation Number: 21 CFR 880.5725 Regulation Name: Infusion Pump Regulatory Class: II Product Code: FRN Dated: October 1, 2012 Received: October 2, 2012
Dear Ms. Eberle:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2- Ms. Eberle
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Anthony D. awat
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Statement
K 122215
510(k) No. (if known):
Device Name:
Navigator™ Delivery System (Navigator DS)
Indications for Use:
The Navigator™ Delivery System (Navigator DS) is intended for use in the delivery of medication and/or fluids in a controlled manner. The Navigator DS is indicated for use in the intermittent delivery of medications and other fluids in intra-articular applications.
Prescription Use: X (Part 21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page _ of _
Ali (Ch) 10/26/12
(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices
KI22215 510(k) Number: _